XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements Of Cash Flows
$ in Thousands
 9 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Net income $ 208,032 $ 154,461  
Impairment, Long-Lived Asset, Held-for-Use 0 11,812  
Impairment charges on joint ventures 0 12,130  
Gain on sale of real estate and early ground lease termination (34,236) (15,989)  
Deferred income tax benefit (676) (1,254)  
Write off of Deferred Debt Issuance Cost 0 337  
Equity in loss from joint ventures (1,394) (5,384)  
Proceeds from Equity Method Investment, Distribution 11 0  
Financing Receivable, Credit Loss, Expense (Reversal) 9,462 2,371  
Depreciation and amortization 125,578 124,738  
Amortization of deferred financing costs 6,428 6,657  
Amortization of above/below market leases and tenant allowances, net (243) (252)  
Share-based Payment Arrangement, Noncash Expense 11,686 10,494  
share based compensation included in severance expense 847 1,598  
Increase (Decrease) in Operating Lease Assets and Liabilities, Net (1,048) (975)  
Mortgage notes accrued interest receivable (2,245) (2,720)  
Accounts receivable (10,272) (16,129)  
Other assets (3,559) (7,176)  
Accounts payable and accrued liabilities 9,528 12,031  
Increase (Decrease) in Deferred Revenue 2,486 2,681  
Net cash provided by operating activities 323,173 300,199  
Investing activities:      
Payments to Acquire Productive Assets 23,914 42,388  
Proceeds from Sale of Productive Assets 125,697 65,149  
Payments to Acquire Interest in Subsidiaries and Affiliates (1,432) (186)  
Investment in mortgage notes receivable (48,073) (88,577)  
Proceeds from Sale and Collection of Mortgage Notes Receivable 9,633 457  
Proceeds from promissory note receivable paydown 1,259 1,289  
Additions to properties under development (69,676) (81,386)  
Net cash used by investing activities (6,506) (145,642)  
Financing activities:      
Proceeds from long-term debt facilities 484,000 214,000  
Repayments of Long-Term Debt (580,000) (181,638)  
Deferred financing fees paid (446) 0  
Proceeds from (Payment for) Other Financing Activity 0 (9,534)  
Net proceeds from issuance of common shares 709 589  
Payment, Tax Withholding, Share-based Payment Arrangement (1) 0  
Purchase of common shares for treasury (9,833) (11,375)  
Dividends paid to shareholders (217,393) (209,193)  
Net cash used by financing activities (322,964) (197,151)  
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 290 (67)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (6,007) (42,661)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29,692 38,320 $ 80,981
Cash and Cash Equivalent 13,710 35,328 78,079
Restricted Cash and Cash Equivalent 15,982 2,992 $ 2,902
Supplemental schedule of non-cash activity:      
Transfer of property under development to rental property 98,956 111,805  
Issuance of nonvested shares and restricted share units at fair value, including nonvested shares issued for payment of bonuses 29,719 21,325  
Remeasurement of right-of-use asset from early ground lease termination 7,439 0  
Remeasurement of lease liability from early ground lease termination 10,901 0  
Supplemental disclosure of cash flow information:      
Interest Paid, Excluding Capitalized Interest, Operating Activity 88,067 81,222  
Cash paid during the period for income taxes 2,329 1,471  
Interest cost capitalized 3,154 2,304  
Change in accrued capital expenditures $ (3,736) $ (13,731)